Death’s legal definition must be responsive to advances in technology, and it must delineate between life and death. Knowing where to draw the line is difficult.
AMA J Ethics. 2020;22(12):E1055-1061. doi:
10.1001/amajethics.2020.1055.
Critical race theory tools of evaluating stock characters and counter stories can help clinicians and researchers illuminate experiences of those at the margins.
AMA J Ethics. 2022;24(3):E212-217. doi:
10.1001/amajethics.2022.212.
E. Berryhill McCarty, MA, MSHCPM and Lance Wahlert, PhD
Global transformation demanded by COVID-19 prompts consideration of how prior epidemics have shaped our cultural and sociological understandings of health care experiences.
AMA J Ethics. 2021;23(5):E423-427. doi:
10.1001/amajethics.2021.423.
Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019;21(10):E844-851. doi:
10.1001/amajethics.2019.844.